Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

465
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
465
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

741
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
741
Long-term Depression01:05

Long-term Depression

33.2K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
Long-term Depression01:03

Long-term Depression

3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.1K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

39.7K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
39.7K
Depressants01:28

Depressants

389
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
389

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep deprivation accelerates Parkinson's disease pathology by upregulating LAG3 in astrocytes and disrupting glymphatic system function.

Journal of advanced research·2026
Same author

Distinct gut and oral microbial profiles differentiate patients with symmetric/asymmetric Parkinson's disease.

Frontiers in human neuroscience·2026
Same author

Correction: LRRK2 G2019S mutation contributes to mitochondrial transfer dysfunction in a Drp1-STX17-dependent manner.

Translational neurodegeneration·2026
Same author

Correlation between sarcopenia and changes in oligodendrocyte lineage cells in the brains of Alzheimer's disease model mice.

Experimental gerontology·2026
Same author

Mediation of ghost infarct core on prognosis by venous outflow and net water uptake after stroke thrombectomy.

European radiology·2026
Same author

A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial of lemborexant in adults with insomnia disorder.

Sleep medicine·2025
Same journal

[Clinical analysis of ultrasound-guided percutaneous sclerotherapy combined with radiofrequency ablation in the treatment of intrahepatic biliary cystadenoma].

Zhonghua yi xue za zhi·2026
Same journal

[Metabolic profiles in umbilical cord blood associated with neonatal brain injury in selective fetal growth restriction].

Zhonghua yi xue za zhi·2026
Same journal

[Relationship between the consistency of auxiliary provocation tests with the supine roll test and treatment outcomes for horizontal semicircular canal benign paroxysmal positional vertigo].

Zhonghua yi xue za zhi·2026
Same journal

[Early-and mid-trimester glycolipid metabolism indicators for predicting adverse pregnancy outcomes in normoglycemic women].

Zhonghua yi xue za zhi·2026
Same journal

[Value of a deep learning-based visual model for predicting postoperative upper limb functional recovery after severe acute cervical spinal cord injury].

Zhonghua yi xue za zhi·2026
Same journal

[Eosinophils and futile recanalization after thrombectomy in acute large vessel occlusion stroke: the mediating effect of malignant brain edema].

Zhonghua yi xue za zhi·2026
See all related articles

Related Experiment Video

Updated: Jan 26, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.3K

[Depression associated with movement disorders].

Cheng-jie Mao1, Ju-ping Chen, Wei-dong Hu

  • 1Department of Neurology, Second Affiliated Hospital, Soochow University, Suzhou, China.

Zhonghua Yi Xue Za Zhi
|April 13, 2013
PubMed
Summary
This summary is machine-generated.

Parkinson's disease (PD) and essential tremor (ET) patients exhibit high rates of depression, with similar severity in both groups. Motor symptoms in PD and ET are positively correlated with depression, highlighting the need to address non-motor symptoms.

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.3K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.5K

Related Experiment Videos

Last Updated: Jan 26, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.3K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.3K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.5K

Area of Science:

  • Neurology
  • Psychiatry
  • Movement Disorders

Context:

  • Parkinson's disease (PD) and essential tremor (ET) are common neurological conditions.
  • Depression is a frequent comorbidity in patients with movement disorders.
  • Understanding the incidence and factors associated with depression is crucial for comprehensive patient care.

Purpose:

  • To investigate the prevalence of depression in patients diagnosed with Parkinson's disease (PD) and essential tremor (ET).
  • To identify associated factors, including motor symptom severity and non-motor symptoms, contributing to depression in these patient groups.
  • To compare the incidence and characteristics of depression between PD and ET patients.

Summary:

  • A study involving 121 PD patients and 62 ET patients found high depression rates: 56.2% in PD and 53.2% in ET.
  • Depression severity was comparable between groups, with mild, moderate, and severe categories showing similar distributions.
  • Motor symptom severity (UPDRS-III for PD, Tremor Rating Scale for ET) positively correlated with depression scores (HAMD) in both patient cohorts (r=0.511, P<0.01 for PD; r=0.828, P<0.01 for ET).

Impact:

  • These findings underscore the significant burden of depression in both Parkinson's disease and essential tremor.
  • The positive correlation between motor and depressive symptoms suggests a complex interplay requiring integrated treatment approaches.
  • Emphasizes the importance of screening for and managing non-motor symptoms, particularly depression, in essential tremor patients, similar to current practices in Parkinson's disease.